All In Biotech

Drug Trial Radar · NCT06410924

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Treatment With DD01 for 48 Weeks in Overweight/Obese Subjects With MASLD/MASH

Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

67

Actual

Start

Jun 13, 2024

Primary completion

May 20, 2025

Study completion Apr 21, 2026

Sponsor

Lead sponsor
Neuraly, Inc.Industry
Sponsor type
Industry
First posted
May 13, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 Study to evaluate the effect of DD01 treatment in overweight/obese patients with metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH).

Conditions

  • NAFLD
  • NASH

Interventions

  • DD01Drug

    Dual GLP-1 and glucagon receptor agonist

  • PlaceboDrug

    Placebo matching DD01

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects who achieve at least 30% liver fat reduction measured by MRI-PDFFTime frame: 12 weeks

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Summit Research Site

    Maitland, Florida

  • Summit Research Site

    Monroe, Louisiana

  • Summit Research Site

    West Monroe, Louisiana

  • Summit Research Site

    Kansas City, Missouri

  • Summit Research Site

    Austin, Texas

  • Summit Research Site

    Bellaire, Texas

  • Summit Research Site

    Brownsville, Texas

  • Summit Research Site

    Corpus Christi, Texas

  • Summit Research Site

    Edinburg, Texas

  • Summit Research Site

    Georgetown, Texas

  • Summit Research Site

    San Antonio, Texas

  • Summit Research Site

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.